References
Grohmann U, Orabona C, Fallarino F et al (2002) CTLA-4-Ig regulates tryptophancatabolism in vivo. Nat Immunol 3:1097–1101
Moreland L, Alten R, van den Bosch F et al (2002) Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum 46:1470–1479
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krüger, K. Selektive Hemmung der T-Zell-Aktivierung durch das Fusionsprotein CTLA4Ig als neues Therapieprinzip für die RA. Z. Rheumatol. 64, 40–41 (2005). https://doi.org/10.1007/s00393-005-0620-0
Issue Date:
DOI: https://doi.org/10.1007/s00393-005-0620-0